Singapore Biodesign

Singapore Biodesign, a National-level talent development platform and global affiliate of the renowned Stanford Byers Center for Biodesign, focuses on bringing economic benefits and healthcare value through its healthtech innovation training. The programme aims to empower the next generation of med-/healthtech innovators for Asia using the needs-centric Biodesign Process that the programme has adapted for the region. The programme focuses on 3 main areas - building Talent, Innovations and the Community.

Celebrating Our Growth Since 2011

59 
FUNDED PROJECTS

16
SPIN-OFFS

>1500 
TALENTS TRAINED

>45
LOCAL & REGIONAL PARTNERS



Happenings & Updates

Untitled design (61)

Message from
Dr Mary Kan

Read Full Statement 

Empowering Your Ideas from Concept to Creation (6)

Application Open for SB Early Prototyping Support Fund 

Find Out More 

S_142

Health and MedTech Events by SB Partners & Local Ecosystem

Find Out More 

Our Capabilities

We provide high-touch mentorship and on-the-job training for motivated individuals in healthtech innovation.

Icon_Talent

Talent

High-touch mentoring of multi-disciplinary teams in the Medtech innovation process

Learn More

Icon_Innovations

Innovations

Collaboration within the local and regional ecosystem to increase the throughput of projects for economic value and healthcare adoption

Learn More

Icon_Community

Community

Building on our local and international community to advance our health technologies goals

Learn More

  • Testimonials

    "Our Singapore Biodesign program provides an “all the way” framework for clinicians and engineers to identify an important clinical question, evaluate the current options, and design strategies to implement sustainable solutions to address that clinical question. It’s a program the forms the foundation for innovation in medicine and healthcare."

    Prof Wong Tien Yin
    Medical Director
    Singapore National Eye Centre 

  • Testimonials

    “Over the past 20 years, the Stanford Biodesign alumni from our US-based and partner programs in Singapore, Japan, and India have used the process to launch nearly 100 start-ups based on technologies that have been used to help many millions of patients. Now as an independent entity, Singapore Biodesign is exceptionally well positioned to sustain and advance this legacy in the Asia Pacific region."

    Prof Paul Yock
    Founder & Director
    Stanford Byers Center for Biodesign, Stanford University